SERINE ARGININE PROTEIN KINASE-1 (SRPK1) INHIBITION AS A POTENTIAL NOVEL TARGETED THERAPEUTIC STRATEGY IN PROSTATE CANCER.PDF

SERINE ARGININE PROTEIN KINASE-1 (SRPK1) INHIBITION AS A POTENTIAL NOVEL TARGETED THERAPEUTIC STRATEGY IN PROSTATE CANCER.PDF

SERINE ARGININE PROTEIN KINASE-1 (SRPK1) INHIBITION AS A POTENTIAL NOVEL TARGETED THERAPEUTIC STRATEGY IN PROSTATE CANCER

Europe PMC Funders Group Author Manuscript Oncogene. Author manuscript; available in PMC 2016 February 13. Published in final edited form as: Oncogene. 2015 August 13; 34(33): 4311–4319. doi:10.1038/onc.2014.360. E u SERINE ARGININE PROTEIN KINASE-1 (SRPK1) INHIBITION AS r o p e A POTENTIAL NOVEL TARGETED THERAPEUTIC STRATEGY IN P M PROSTATE CANCER C F u 1 1 1

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档